Cargando…
Bexarotene Reduces Production of CCL22 From Tumor-Associated Macrophages in Cutaneous T-Cell Lymphoma
Bexarotene is a third-generation retinoid X receptor-selective retinoid that has been approved for use in the treatment of both early and advanced cutaneous T-cell lymphoma (CTCL). Although bexarotene has been used for decades in the treatment of CTCL, little is known about the mechanisms underlying...
Autores principales: | Tanita, Kayo, Fujimura, Taku, Sato, Yota, Lyu, Chunbing, Kambayashi, Yumi, Ogata, Dai, Fukushima, Satoshi, Miyashita, Azusa, Nakajima, Hideki, Nakamura, Motoki, Morita, Akimichi, Aiba, Setsuya |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6763730/ https://www.ncbi.nlm.nih.gov/pubmed/31616630 http://dx.doi.org/10.3389/fonc.2019.00907 |
Ejemplares similares
-
Successful Treatment of Primary Cutaneous Peripheral T-Cell Lymphoma Presenting Acquired Ichthyosis with Oral Bexarotene Monotherapy
por: Tanita, Kayo, et al.
Publicado: (2017) -
Successful Treatment of Advanced Primary Cutaneous Peripheral T-Cell Lymphoma with Oral Bexarotene Monotherapy
por: Sato, Yota, et al.
Publicado: (2018) -
Widely Spread Unilateral Inflammatory Linear Verrucous Epidermal Nevus (ILVEN)
por: Tanita, Kayo, et al.
Publicado: (2018) -
Intensity-Modulated Radiotherapy Triggers Onset of Bullous Pemphigoid in a Patient with Advanced Melanoma Treated with Nivolumab
por: Tanita, Kayo, et al.
Publicado: (2018) -
Possible Roles of Proinflammatory Signaling in Keratinocytes Through Aryl Hydrocarbon Receptor Ligands for the Development of Squamous Cell Carcinoma
por: Sato, Yota, et al.
Publicado: (2020)